/news

Price Alert: Shares of C4 (CCCC) Trade 7.40% Higher at Midday June 22

Equities Staff  |

C4 Therapeutics Inc (NASDAQ: CCCC) shares moved 7.40%, or $0.41 per share, as on 11:51:03 est today. Since opening the day at $5.42, 361,631 shares of C4 have been traded today and the stock has traded between $6.03 and $5.40.  

This year the company has a YTD change of 82.80%.

C4 expects its next earnings on 2022-08-10.

For technical charts, analysis, and more on C4 visit the company profile.

About C4 Therapeutics Inc

C4 Therapeutics is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.

To get more information on C4 Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: C4 Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Will Mining Stocks Fall Further?
3 Reasons To Be Optimistic About the Global Shipping Industry
The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks



Market Movers

Sponsored Financial Content